Basic Information
Strain Establishment
In the severely immunodeficient mice NPG, the complete genomic sequence of the human HLA-A11.1 gene, along with the 5' and 3' UTR sequences, was randomly introduced into the mice using transgenic methods, enabling the expression of human HLA-A11.1. This strain lacks T, B, and NK cells.
Application Fields of NPG-HLA-A11.1 Mice
1. Hematopoietic stem cell transplantation, studying the development of human blood and immune systems
2. Vaccine research
3. Immunology-related research